Drrx stock forecast.

VINCW. Vincerx Pharma, Inc. 1.6100. -0.4200. -20.69%. In this article, we will take a look at the 10 oversold penny stocks to buy. To see more such companies, go directly to 5 Oversold Penny ...Stock Price Forecast The 4 analysts offering 12-month price forecasts for DURECT Corp have a median target of 34.50, with a high estimate of 44.00 and a low estimate of 32.00. The median estimate represents a +984.91% increase from the last price of 3.18.Analyst Forecast. According to 4 analysts, the average rating for DRRX stock is "Buy." The 12-month stock price forecast is $36.5, which is an increase of 5,883.61% from the latest price.Find the latest Galera Therapeutics, Inc. (GRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Durect (NASDAQ: DRRX) stock is falling hard on Wednesday after the late-stage biopharmaceutical company released results from a Phase 2b clinical trial. This clinical trial covered the efficiency ...

Summary. DRRX is a forever laggard company. In 2021, I noted its strong phase 2a data. There's phase 2b data this year, but the market is completely ignoring this stock.

DRRX stock has a “B” rating in the Portfolio Grader. Dynavax Technologies (DVAX) Dynavax Technologies DVAX is a commercial-stage biotech company focusing is on getting drugs over the finish line (approval from the Food & Drug Administration and other regulators in other countries) and available for sale.Their DRRX share price targets range from $27.00 to $41.00. On average, they expect the company's stock price to reach $34.25 in the next twelve months. This suggests a possible upside of 5,194.5% from the stock's current price. View analysts price targets for DRRX or view top-rated stocks among Wall Street analysts.

DURECT Corp ( DRRX) is up 3.29% today. DRRX has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on DRRX! DRRX stock closed at $7.00 and is up $0.23 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard …DRTT one year forecast. DIRTT Environmental Solutions stock monthly and weekly forecasts. Skip to content. FORECST.COM 2023 – 2026 Stock Market Forecast DRTT stock forecast for 2023 – 2027. Last updated: November 25, 2023. ... Other companies stock forecasts. DRRX Stock Forecast; DRQ Stock Forecast;DURECT Corporation Common Stock (DRRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Find the latest DURECT Corporation (DRRX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. ... Latest Stock Analysis. Follow $0.66 0.01 (+1 ...

However, it does not forecast the overall direction of its price. In a nutshell, if Durect's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Durect stock will not fluctuate a lot when Durect's options are near their ...

Research DURECT's (Nasdaq:DRRX) stock key valuation metrics while comparing it with its industry peers & market side by side. Research DURECT's ... The above table shows the analyst DRRX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts ...

The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock ...Oct 15, 2020 · The Durect stock forecast is 1.3653368157524 USD for 2024 November 26, Tuesday; and 6.830 USD for 2028 November 26, Sunday with technical analysis. Durect (DRRX) stock price prediction is 1.3653368157524 USD. Buying a stock under $10 means that for that same $100 you can pick up 10 shares instead of just one. Generally, stocks under $10 to buy are more likely to be growth stocks with longer runways to ...Find the latest CPS Technologies Corporation (CPSH) stock quote, history, news and other vital information to help you with your stock trading and investing.The 4 analysts offering 1 year price forecasts for DRRX have a max estimate of — and a min estimate of —. Analyst rating Based on 4 analysts giving stock ratings to DRRX in the past 3 months.Comtech Telecommunications Corp. -0.84%. $335.84M. GSAT | Complete Globalstar Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.3 analysts have issued 12-month price objectives for Broadwind's stock. Their BWEN share price targets range from $6.00 to $9.00. On average, they predict the company's share price to reach $7.67 in the next twelve months. This suggests a possible upside of 250.1% from the stock's current price. View analysts price targets for BWEN or …DURECT Corporation Common Stock (DRRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Get the latest Oncology Pharma Inc (ONPH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Find the latest Earnings Report Date for DURECT Corporation Common Stock (DRRX) at Nasdaq.com.

The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.00 per share and accompanying warrant, and the pre-funded warrants are being sold at a ...Planning a trip can be an exciting but challenging task. From booking accommodations to creating an itinerary, there are countless details to consider. One crucial aspect that should never be overlooked is checking the 7-day weather forecas...

VINCW. Vincerx Pharma, Inc. 1.6100. -0.4200. -20.69%. In this article, we will take a look at the 10 oversold penny stocks to buy. To see more such companies, go directly to 5 Oversold Penny ...Financial Health criteria checks 5/6. DURECT has a total shareholder equity of $14.4M and total debt of $18.7M, which brings its debt-to-equity ratio to 129.8%. Its total assets and total liabilities are $54.7M and $40.3M respectively.Find the latest Durect Corporation (DRRX) stock forecast, 12-month price target, predictions and analyst recommendations.Nov 28, 2023 · DRRX's stock price has decreased by -84.09% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 2 stock analysts, the average 12-month stock price forecast for DURECT stock is $36.5, which predicts an increase of 5,499.88%. Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Based on short-term price targets offered by two analysts, the average price target for Durect comes to $6.75. The forecasts range from a low of $5.00 to a high of $8.50. The average price target ...Real time Durect (DRRX) stock price quote, stock graph, news & analysis.

For DURECT stock forecast for 2026, 12 predictions are offered for each month of 2026 with average DURECT stock forecast of $0.87, a high forecast of $1.25, and a low forecast of $0.48. The average DURECT stock forecast 2026 represents a 39.89% increase from the last price of $0.620000004768372.

DURECT (NASDAQ:DRRX) stock price plunges 31% as it entered into definitive agreements for the purchase and sale of an aggregate of 2.99M shares of common stock and warrants to purchase up to 2.99M ...

See historical performance and comparison. View Valuation. Research DURECT's (Nasdaq:DRRX) stock price, latest news & stock analysis. Find everything …Get the latest DURECT Corporation (DRRX) stock news and headlines to help you in your trading and investing decisions.Nevertheless, analysts rate DRRX a unanimous strong buy with a $29.80 target, implying 1,097% upside. On the date of publication, ... PayPal Stock Is a No-Gainer, Not a No-BrainerDurect Corp [DRRX] stock prices are up 4.33% to $0.65 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The DRRX shares have gain 3.03% over the last week, with a monthly amount drifted -73.90%, and not seem to be holding upDURECT Corporation Announces $10 Million Registered Direct Offering of Common Stock and Warrants. CUPERTINO, Calif., Feb. 3, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a ...Find the latest Galera Therapeutics, Inc. (GRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Zacks Equity Research. A downtrend has been apparent in Durect (DRRX) lately with too much selling pressure. The stock has declined 17.1% over the past four weeks. However, given the fact that it ...Complete Durect Corp. stock information by Barron's. View real-time DRRX stock price and news, along with industry-best analysis.Durect (NASDAQ: DRRX) stock is falling hard on Wednesday after the late-stage biopharmaceutical company released results from a Phase 2b clinical trial. This clinical trial covered the efficiency ...Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...1 equities research analysts have issued 1 year price targets for Cassava Sciences' shares. Their SAVA share price targets range from $11.00 to $124.00. On average, they predict the company's share price to reach $54.33 in the next year. This suggests a possible upside of 154.5% from the stock's current price.DURECT Co. (NASDAQ:DRRX – Free Report) – Northland Capmk boosted their FY2023 EPS estimates for shares of DURECT in a report issued on Tuesday, November 14th. Northland Capmk analyst C. Byrnes now anticipates that the specialty pharmaceutical company will post earnings per share of ($1.47) for the year, up from …

Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. $233.0401 -1.2599 -0.54%. $190.76 +1.07. DURECT Corporation Common Stock ...Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Mar 24, 2023 · DRRX stock has massive potential and is up 32% so far this year. Analysts have a price target of $34.50, which would be a lofty 650% bump. DRRX stock has a “B” rating in the Portfolio Grader. Instagram:https://instagram. robert kiyosaki buy silver1 dollar 1979 coin valuewhat is the best humana dental planbest home loans in texas Get the latest Marker Therapeutics Inc (MRKR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. avista corpbest banks in delaware Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET.Story continues. DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company focused on developing epigenetic regulator programs for the treatment of acute organ injury and chronic liver ... j.b. hunt trucking The latest Durect stock prices, stock quotes, news, and DRRX history to help you invest and trade smarter. ... Vanguard Total Stock Market ETF: 2.48: Armistice Capital LLC: 2.21: Vanguard Russell ...Jan 13, 2022 10:00AM EST. A downtrend has been apparent in Durect (DRRX) lately with too much selling pressure. The stock has declined 17.1% over the past four weeks. However, given the fact that ...Let’s talk about penny stocks. These are equities that trade for less than $5 per share, at the very bottom of the price range. While they are priced that low for a reason – and the reasons may vary – a low price in itself doesn’t mean that the stock’s fundamentals are sour. Smart investors […]